Liver Cancer Cell Lines
Database

LCCL to predict drug response

Drug: Brivanib

DrugsAliasTargetsTargeted cellular functionClinical status in any tumor typeClinical status in HCCSupplierReference
Brivanib BMS-540215 VEGFR1, 2 and 3, FGFR1, 2 and 3 Tyrosine kinases Phase 1, 2, 3 Phase 3 Selleck Chemicals S1084

Cell Line (34)
Cell LineAUCGI50
Hep3B0.9410.0
Huh70.9610.0
Li70.9810.0
JHH70.9910.0
HepG20.9910.0
SNU8781.010.0
HLE1.010.0
JHH21.0110.0
HepaRG1.0110.0
Huh61.0110.0
HCC.1.21.0110.0
HLF1.0110.0
HCC.31.0110.0
SNU7391.0110.0
SNU4231.0310.0


LCCL transcriptomic subgroup:
CL1
CL2
CL3
undef.

Codebase Soc. Coop.
info@codebase.it